• Trypanosoma cruzi (T. cruzi) Antibody, IgG
  • Influenza Virus Type A, B and Respiratory Syncytial Virus (RSV), PCR
  • Retinoic Acid Receptor Gamma (RARG) Genotyping
  • Organic Acids, Urine
  • Anti-SARS-CoV-2 (Coronavirus), IgM
  • Vancomycin, Trough, Serum
  • Dexedrine (Dextroamphetamine), Urine
  • Circulating Tumor Cells (CTC), Prostate Cancer
  • Hereditary Neuroendocrine Tumor Gene Mutation Panel, NGS
  • Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis
Medical Test

Clinical Utility
Access to Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis is restricted.